Results 31 to 40 of about 6,399,450 (255)
Stem Cells Therapy for Ischemic Heart Disease
Despite major advances in the management of ischemic heart disease, it remains a leading cause of morbidity and mortality worldwide. To overcome this epidemiological issue, among different treatment options, there has been interest in applying cellular ...
Gerosa G., Pradegan N.
core +1 more source
Research on heart failure in Colombia, time to take a step forward
Cardiovascular diseases are the leading cause of death worldwide. According to the Ministry of Health, in Colombia, cardiac ischemic disease ranks first, followed by stroke, diabetes and hypertensive heart disease, which are in the top ten sources of ...
Guillermo Mora Pabón
doaj +1 more source
The Arachidonate 15-Lipoxygenase Enzyme Product 15-HETE Is Present in Heart Tissue from Patients with Ischemic Heart Disease and Enhances Clot Formation. [PDF]
Ischemic heart disease is a major cause of death and morbidity and the search for novel therapeutic targets is still required. We have previously shown that the enzyme arachidonate 15 lipoxygenase (ALOX15), which catalyzes the conversion of arachidonic ...
Annika Lundqvist +6 more
doaj +1 more source
Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]
<p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Tracey Baird +11 more
core +1 more source
Mortality Trends from Ischemic Heart Disease in Turkey: 2009-2019
Objective: Cardiovascular diseases still play an important role in public health and epidemiology as the leading cause of death worldwide. Ischemic heart disease is the most common reason in this group.
Doğan, Nurhan +6 more
core +1 more source
ABSTRACT Background Maintenance hemodialysis (MHD) patients frequently suffer from frailty, characterized by reduced physical function and poor prognosis. Myokines, such as myonectin, secreted by muscle, are emerging regulators of systemic health. This study investigated the relationship between serum myonectin, adipokines (adiponectin, omentin), and ...
Kenichi Kono +7 more
wiley +1 more source
Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial [PDF]
<p><b>Background and Purpose:</b> The relationship between baseline and recurrent vascular events may be important in the targeting of secondary prevention strategies. We examined the relationship between initial event and various types
C. Tzourio +24 more
core +1 more source
Familial Aggregation for Ischemic Heart Disease
Background: ischemic heart disease is a nosological entity of multifactorial origin with genetic predisposition and susceptible to environmental changes. Objective: to determine the existence of familial aggregation for ischemic heart disease in patients
José Leandro Pérez Guerrero +1 more
doaj
Study the dynamics of oxidative stress in the blood of patients with ischemic heart disease before and after on-pump coronary bypass surgery. 27 ischemic heart disease patients were examined.
N. L. Vorontsova +7 more
doaj +1 more source
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source

